In 2000, UK-based Glaxo Wellcome joined forces with SmithKline Beecham in a $74 billion merger that birthed the global pharma giant GlaxoSmithKline. It was, far and away, the biggest biopharma deal of the year.
What a difference 14 years makes.
In 2014, there were more than 180 M&A deals in the biotech and pharmaceutical spheres, totaling $212 billion. And if the breakneck pace of biopharma deals in just the last three months is any indication, the sector doesn’t plan on slowing down consolidation anytime soon.
Hey, check out all the research scientist jobs. Post your resume today!
